AngioDynamics, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Shows the company's full-year money, assets, and debts to help investors understand its financial health.
Announces quarterly and annual earnings results that tell investors how well the company performed.
Protects the company's inventions and could win money if it wins, affecting future profits.
Shows quarterly earnings and financial position to help investors track company progress.
Shares quarterly earnings results and strategy slides so investors understand recent performance.
Leadership change affects company direction; new CEO appointment is important for investor confidence.
Stocky reads AngioDynamics, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
AngioDynamics, Inc.'s most recent tracked filing was a 10-K on 14 Jul 2026: Annual financial report for fiscal year ended May 31, 2026.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.